https://www.selleckchem.com/pr....oducts/coelenterazin
To measure utilities among cancer patients, a cancer-specific utility instrument called the European Organization for Research and Treatment of Cancer (EORTC) QLU-C10D has been developed based on EORTC quality of life core module (QLQ-C3. This study aimed to provide Dutch utility weights for the QLU-C10D. A cross-sectional valuation study was performed in 1017 participants representative in age and gender of the Dutch general population. The valuation method was a discrete choice experiment containing 960 choice sets, i.e. pair
Мне нравится
Комментарий
Перепост
